catalog number :
MBS537887
products type :
Native Protein
products full name :
Complement C9 protein
products short name :
Complement C9
products name syn :
C9 protein
other names :
complement component C9; Complement component C9; complement component C9; complement component 9
other gene names :
C9; C9; C9D; ARMD15
uniprot entry name :
CO9_HUMAN
form :
Supplied as a liquid in PBS, pH 7.2, no preservatives added,
concentration :
1.03mg/ml
storage stability :
Aliquot and store at -70 degree C or lower. Avoid repeated freeze/thaw cycles. Shipping: Ships with Dry Ice.
other info1 :
Source Note: Human serum/plasma. Protein Type: Native. Biological Significance: Native human C9 is a naturally glycosylated (7.8%) protein composed of a single polypeptide chain. The molecular weight is 71,000 Da. C9 binds to the C5b-8 complex and forms the mature membrane attack complex (MAC) on cell membranes. Each pathway of complement activation generates proteolytic enzyme complexes (C3/C5 convertases) which are bound to the target surface. These enzymes cleave a peptide bond in the larger alpha chain of C5 releasing the anaphylatoxin C5a and activating C5b.
other info2 :
Biohazard Information: Use appropriate laboratory precautions when handling this product. Dry Ice Shipment: Extra charge fee may add to your shipping cost as dry ice is required to ship this product. Functional Activity: 255,000kU/mg, >100% of C9 in NHS on a mg/mg basis.
products categories :
Immunology; Native Protein; Complements
products description :
Purified Complement C9 protein isolated from human plasma
ncbi acc num :
NP_001728.1
ncbi gb acc num :
NM_001737.3
ncbi pathways :
Amoebiasis Pathway (167324); Amoebiasis Pathway (167191); Complement Activation, Classical Pathway (198823); Complement And Coagulation Cascades Pathway (198880); Complement And Coagulation Cascades Pathway (83073); Complement And Coagulation Cascades Pathway (484); Complement Cascade Pathway (106405); Immune System Pathway (106386); Innate Immune System Pathway (106387); Prion Diseases Pathway (101144)
ncbi summary :
This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009]
uniprot summary :
C9: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC. Defects in C9 are a cause of complement component 9 deficiency (C9D). A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Belongs to the complement C6/C7/C8/C9 family. Protein type: Membrane protein, multi-pass; Membrane protein, integral; Apoptosis; Extracellular matrix. Chromosomal Location of Human Ortholog: 5p14-p12. Cellular Component: membrane attack complex; integral to plasma membrane; cytoplasm; extracellular region; plasma membrane. Biological Process: complement activation, alternative pathway; regulation of complement activation; innate immune response; hemolysis by symbiont of host red blood cells; complement activation, classical pathway. Disease: Macular Degeneration, Age-related, 15; Complement Component 9 Deficiency